14th Mar 2008 11:38
Tissue Science Laboratories PLC14 March 2008 Form TR-1 with annex. FSA Version 2.1 updated April 2007 For filings with the FSA include the annexFor filings with issuer exclude the annex TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying Tissue Science Laboratories plcissuer of existing shares to which voting rights are attached:------------------------------------2. Reason for notification (yes/no)------------------------------------ An acquisition or disposal of voting rights YES------------------------------------------ An acquisition or disposal of financial instruments which may result inthe acquisition of shares already issued to which voting rights are attached------------------------------------------An event changing the breakdown of voting rights------------------------------------------ Other (please specify):______________------------------------------------------ 3. Full name of person(s) subject to Covidien UK Holding Ltdnotification obligation: --------------------------4. Full name of shareholder(s) (ifdifferent from 3): --------------------------5. Date of transaction (and date on which 12 March 2008the threshold is crossed or reached if different):--------------------------6. Date on which issuer notified: 14 March 2008-------------------------- 7. Threshold(s) that is/are crossed orreached: 3%, 4% , 5%, 6%, 7%, 8%,9%,10%, 11%-------------------------- 8: Notified Details A: Voting rights attached to sharesClass/type of Situation previous to the triggering transactionsharesIf possible useISIN codeGB0030978380 Number of shares Number of voting rights nil nil Resulting situation after the triggering transaction Number of shares Number of voting rights Percentage of voting rights Direct Indirect Direct Indirect 3,977,518 3,977,518 11.49% B: Financial InstrumentsResulting situation after the triggering transactionType of Expiration Exercise/ No. of voting rights that may Percentagefinancial date conversion be acquired (if the instrument of votinginstrument period/date exercised/converted) rights Total (A+B)Number of voting rights Percentage of voting rights 3,977,518 11.49% 9. Chain of controlled undertakings through which the voting rights and /or thefinancial instruments are effectively held, if applicable:Covidien UK Holding Ltd is an in-direct wholly owned subsidiary of Covidien Ltd Proxy Voting: 10. Name of proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14 Contact name: Mark Culwick 15. Contact telephone name: 0121 600 5227 For notes on how to complete form TR-1 please see the FSA website. Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in shares A: Identity of the persons or legal entity subject to the notificationobligationFull name(including legal form of legal entities)Contact address(registered office for legal entities)Phone number & emailOther useful information(at least legal representative for legal persons) B: Identity of the notifier, if applicableFull nameContact addressPhone number & emailOther useful information(e.g. functional relationship with the person or legal entity subject to thenotification obligation) C: Additional information This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TSL.L